Grant: Master's Award: Canada Graduate Scholarships
University of Alberta
$17,500.00
Role of fractalkine signaling in developmental myelination
EF 2020-21
Résumé
Multiple sclerosis (MS) is a progressive neurodegenerative disease affecting ~77 000 Canadians. In MS, immune cells attack myelin, the protective coating around nerve axons, leading to physical and/or cognitive decline in affected individuals. In the last few years, over 200 gene mutations have been discovered in MS patients. This has highlighted the role of genetics in MS predisposition, onset, and progression. Many of the identified genes play an important role in inflammation, including CX3CR1, a receptor that interacts with an immunological molecule termed fractalkine (FKN). While it was believed that expression of CX3CR1 was limited to microglia (brain immune cells), our lab has shown CX3CR1 is also expressed in oligodendrocyte precursor cells (OPCs). OPCs participate in brain and spinal cord development and function by generating oligodendrocytes, the only cell type that produce myelin. Our lab has shown defective FKN-CX3CR1 signaling in OPCs affects oligodendrocyte formation in the developing brain. This has raised important questions about the effect of MS-specific CX3CR1 mutations on brain and spinal cord development. Here, I will study the effect of human CX3CR1I249/M280 variant, detected in patients with progressive MS, on developmental myelination. To do this, I will use mouse models that express the pathogenic CX3CR1 gene variant in OPCs only, or in OPCs and microglia. I will analyze brain and spinal cord tissue from birth to adulthood via protein analysis and microscopy. The results from this project will determine cell-specific contribution of CX3CR1 signaling to developmental myelination, and identify if and how MS pathogenic gene variants affect brain and spinal cord development.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
449647
Name
Bibi Sana
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Role of fractalkine signaling in developmental myelination
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Brain Development; Chemokine; Demyelination; Microglia; Multiple Sclerosis; Myelination; Neurodevelopment; Neuronal Damage; Oligodendrocyte; Opc
Abstract
Multiple sclerosis (MS) is a progressive neurodegenerative disease affecting ~77 000 Canadians. In MS, immune cells attack myelin, the protective coating around nerve axons, leading to physical and/or cognitive decline in affected individuals. In the last few years, over 200 gene mutations have been discovered in MS patients. This has highlighted the role of genetics in MS predisposition, onset, and progression. Many of the identified genes play an important role in inflammation, including CX3CR1, a receptor that interacts with an immunological molecule termed fractalkine (FKN). While it was believed that expression of CX3CR1 was limited to microglia (brain immune cells), our lab has shown CX3CR1 is also expressed in oligodendrocyte precursor cells (OPCs). OPCs participate in brain and spinal cord development and function by generating oligodendrocytes, the only cell type that produce myelin. Our lab has shown defective FKN-CX3CR1 signaling in OPCs affects oligodendrocyte formation in the developing brain. This has raised important questions about the effect of MS-specific CX3CR1 mutations on brain and spinal cord development. Here, I will study the effect of human CX3CR1<sup>I249/M280</sup> variant, detected in patients with progressive MS, on developmental myelination. To do this, I will use mouse models that express the pathogenic CX3CR1 gene variant in OPCs only, or in OPCs and microglia. I will analyze brain and spinal cord tissue from birth to adulthood via protein analysis and microscopy. The results from this project will determine cell-specific contribution of CX3CR1 signaling to developmental myelination, and identify if and how MS pathogenic gene variants affect brain and spinal cord development.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bibi, Sana
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~